<DOC>
	<DOCNO>NCT02412813</DOCNO>
	<brief_summary>This prospective , randomize , multi-center , metal hypersensitivity study compare OXINIUM cobalt chrome femoral component subject fail total knee arthroplasty ( TKA ) .</brief_summary>
	<brief_title>LEGIONâ„¢ Revision Metal Hypersensitivity Study</brief_title>
	<detailed_description>A total 230 subject randomize ( 1:1 ) receive either OXINIUM cobalt chrome femoral component part LEGION revision procedure . The objective study ass lower serum metal ion concentration level least one three major mLTTs ( Co , Cr Ni ) 5 year subject receive OXINIUM versus Cobalt Chrome femoral component part LEGION Revision Total Knee System .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>Subject skeletally mature Subject willing sign date IRB/EC approve consent form Subject candidate revision knee replacement Subject meet acceptable preoperative medical clearance free treat cardiac , pulmonary , hematological , infection , condition would pose excessive operative risk Subject agree adhere 10year study visit schedule Subject know metal hypersensitivity Subject require know bilateral revision TKA Subject severe pronation ipsilateral foot relevant clinical condition contribute abnormal ambulation Subject active infection sepsis ( treat untreated ) Subject immunosuppressive disorder Subject presence malignant tumor , metastatic , neoplastic disease Subject condition may interfere TKA survival outcome ( i.e. , Paget 's Charcot 's disease , vascular insufficiency , muscular atrophy , uncontrolled diabetes , moderate severe renal insufficiency neuromuscular disease ) Subject intraarticular corticosteroid therapy ( intraarticular therapy ) study knee within 3 month study enrollment Subject inadequate bone stock support device would require significant augmentation correct joint Female subject childbearing age unwilling use approve method contraception Subject emotional neurological condition would preempt ability willingness comply study Subject severely overweight ( BMI &gt; 40 ) Subject currently enrol another investigational drug , biologic , device study treat investigational product past 30 day Subject facing current impending incarceration</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hypersensitivity</keyword>
	<keyword>metal sensitivity</keyword>
	<keyword>arthroplasty</keyword>
	<keyword>implant-related hypersensitivity</keyword>
	<keyword>metal-on-metal implant</keyword>
	<keyword>knee revision</keyword>
</DOC>